LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,069 | -72.6% | 21,164 | -42.5% | 0.00% | – |
| Q2 2023 | $84,328 | +125.9% | 36,825 | +139.7% | 0.00% | – |
| Q1 2023 | $37,332 | +1766.6% | 15,363 | +1918.8% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 761 | -42.7% | 0.00% | – |
| Q2 2022 | $2,000 | -99.5% | 1,327 | -99.3% | 0.00% | – |
| Q1 2022 | $376,000 | -80.6% | 179,952 | -63.5% | 0.00% | – |
| Q4 2021 | $1,941,000 | -27.0% | 492,731 | -10.9% | 0.00% | -100.0% |
| Q3 2021 | $2,660,000 | +97.5% | 552,963 | +88.5% | 0.00% | – |
| Q2 2021 | $1,347,000 | +372.6% | 293,408 | +503.7% | 0.00% | – |
| Q1 2021 | $285,000 | +44.7% | 48,600 | -15.5% | 0.00% | – |
| Q4 2020 | $197,000 | -8.8% | 57,487 | -61.7% | 0.00% | – |
| Q3 2020 | $216,000 | -0.5% | 150,093 | +38.1% | 0.00% | – |
| Q2 2020 | $217,000 | +2.4% | 108,667 | +0.2% | 0.00% | – |
| Q1 2020 | $212,000 | -28.9% | 108,461 | +50.6% | 0.00% | – |
| Q4 2019 | $298,000 | +351.5% | 71,996 | +226.7% | 0.00% | – |
| Q3 2019 | $66,000 | -49.6% | 22,037 | +5.7% | 0.00% | – |
| Q2 2019 | $131,000 | -7.1% | 20,844 | -17.5% | 0.00% | – |
| Q1 2019 | $141,000 | -16.6% | 25,252 | -0.3% | 0.00% | – |
| Q4 2018 | $169,000 | -37.6% | 25,337 | -0.3% | 0.00% | – |
| Q3 2018 | $271,000 | -10.0% | 25,401 | +1.2% | 0.00% | – |
| Q2 2018 | $301,000 | -23.4% | 25,101 | -45.3% | 0.00% | – |
| Q1 2018 | $393,000 | -26.5% | 45,924 | -15.2% | 0.00% | – |
| Q4 2017 | $535,000 | -61.4% | 54,156 | -52.0% | 0.00% | – |
| Q3 2017 | $1,385,000 | -5.0% | 112,721 | +27.2% | 0.00% | – |
| Q2 2017 | $1,458,000 | +4.8% | 88,590 | -8.7% | 0.00% | – |
| Q1 2017 | $1,391,000 | -9.0% | 97,024 | -12.3% | 0.00% | -100.0% |
| Q4 2016 | $1,529,000 | -60.5% | 110,584 | -48.3% | 0.00% | 0.0% |
| Q3 2016 | $3,868,000 | +268.7% | 214,057 | +192.8% | 0.00% | – |
| Q2 2016 | $1,049,000 | +16.0% | 73,104 | -3.4% | 0.00% | – |
| Q1 2016 | $904,000 | +326.4% | 75,650 | +374.6% | 0.00% | – |
| Q4 2015 | $212,000 | -19.7% | 15,939 | -35.1% | 0.00% | – |
| Q3 2015 | $264,000 | +116.4% | 24,566 | +62.4% | 0.00% | – |
| Q2 2015 | $122,000 | – | 15,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |